{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:07:11Z","timestamp":1791446831264,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.amjcard.2012.04.034","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T01:28:40Z","timestamp":1337650120000},"page":"607-613","source":"Crossref","is-referenced-by-count":35,"title":["Meta-Analysis of Cardiovascular Outcomes With Dronedarone in Patients With Atrial Fibrillation or Heart Failure"],"prefix":"10.1016","volume":"110","author":[{"given":"Saurav","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joydeep","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Lichstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamik","family":"Aikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.04.034_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1358\/dot.2006.42.2.925346","article-title":"Dronedarone: a new antiarrhythmic agent","volume":"42","author":"Zareba","year":"2006","journal-title":"Drugs Today (Barc)"},{"issue":"suppl","key":"10.1016\/j.amjcard.2012.04.034_bib2","first-page":"269","article-title":"Electrophysiological characteristics of dronedarone (SR 33589), a new amiodarone-like agent, in cardiac ventricular myocytes","volume":"18","author":"Gautier","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.04.034_bib3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjp.0703446","article-title":"Effects of dronedarone on acetylcholine-activated current in rabbit SAN cells","volume":"130","author":"Altomare","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/01.CIR.100.22.2276","article-title":"Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone","volume":"100","author":"Sun","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.04.034_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0195-668X(03)00321-X","article-title":"Dronedarone for prevention of atrial fibrillation: a dose-ranging study","volume":"24","author":"Touboul","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.04.034_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.04.034_bib10","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib11","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2012.04.034_bib14","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib15","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011"},{"issue":"suppl","key":"10.1016\/j.amjcard.2012.04.034_bib16","first-page":"e1","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and Safety of Dronedarone for the Control of Ventricular Rate during Atrial Fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.04.034_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4137\/CMC.S6677","article-title":"Safety and efficacy of dronedarone in the treatment of atrial fibrillation\/flutter","volume":"5","author":"Naccarelli","year":"2011","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"107","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1074248406290678","article-title":"Dose-dependent effects of oral dronedarone on the circadian variation of RR and QT intervals in healthy subjects: implications for antiarrhythmic actions","volume":"11","author":"Wadhani","year":"2006","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2012.04.034_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s12325-011-0086-1","article-title":"The management of patients with atrial fibrillation and dronedarone's place in therapy","volume":"28","author":"Cohen","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.amjcard.2012.04.034_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005049.pub2","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"4","author":"Lafuente-Lafuente","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2012.04.034_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2010.11.047","article-title":"2011 ACCF\/AHA\/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"8","author":"Wann","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2012.04.034_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005344-199509000-00016","article-title":"SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats","volume":"26","author":"Manning","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0705502","article-title":"Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1\/minK potassium channels","volume":"140","author":"Thomas","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.amjcard.2012.04.034_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.04.034_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0b013e31821106c9","article-title":"Dronedarone-induced digoxin toxicity: new drug, new interactions","author":"Vallakati","year":"2011","journal-title":"Am J Ther"},{"issue":"suppl","key":"10.1016\/j.amjcard.2012.04.034_bib27","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1345\/aph.1Q217","article-title":"Elevated international normalized ratio associated with use of dronedarone and warfarin","volume":"45","author":"Pogge","year":"2011","journal-title":"Ann Pharmacother"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912011940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912011940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T04:27:09Z","timestamp":1542947229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912011940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0002914912011940"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.04.034","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}